Crossix ScoreBoard™ Reports

Crossix ScoreBoard™ and other reports utilize powerful analytics to measure business impact based on actual Rx activity to support the entire marketing lifecycle – across campaigns, across channels, across tactics, including:

  • Rx Profile – reaching the right audience
  • Conversions to product – new patient starts
  • Retention/Adherence to product – incremental Rx
  • Additional standard and custom reports

The reports derive key measurements from actual Rx data and present aggregated results for groups of consumers/patients. Crossix works with clients to tailor the reports to address the specific requirements of the client (e.g., business rules, competitive sets, etc.). Standardized business rules support comparisons and learnings over time and across campaigns, channels and even brands.

Reports provide early performance markers and can be updated regularly. The unique Crossix methodology allows for efficient and cost effective subscriptions for regular updates, driving real-time decision-making and substantial gains in marketing and cost effectiveness for clients – optimization, not just after-the-fact measurement. Many clients take advantage of monthly or quarterly reporting.

In addition to the suite of standard reports, Crossix can provide custom reports and consulting services designed to meet any client's needs.

Crossix RxMarketMetrics™ provides market benchmarks for performance of patient and consumer marketing activities based on the breadth of actual Crossix ScoreBoard™ and other Rx analyses completed.

Crossix analytical process specifically complies with privacy laws and regulations, including HIPAA; in fact, it's a state-of-the-art process, not only in terms of providing better results, but also in terms of a principled respect for privacy, by design.

ScoreBoard Reports answer these questions so you can measure the impact and drive better performance

Learn more about Best Practices for measurement and optimization, or if you are interested in more information, contact us.